切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2017, Vol. 14 ›› Issue (03) : 226 -231. doi: 10.3877/cma.j.issn.1672-6448.2017.03.012

所属专题: 乳腺超声 文献

浅表器官超声影像学

钼靶微钙化阴性乳腺单纯性导管内癌患者超声及病理表现
刘德泉1, 丁红宇2,(), 崔晶3, 史浩4, 张凯5, 范凤景5, 李菲6   
  1. 1. 271000 泰安,泰山医学院;252800 聊城,高唐县人民医院超声科
    2. 250014 济南,山东省千佛山医院超声诊疗科
    3. 250014 济南,山东省千佛山医院病理科
    4. 250014 济南,山东省千佛山医院影像科
    5. 271000 泰安,泰山医学院
    6. 250014 济南,山东大学齐鲁医学部
  • 收稿日期:2016-06-05 出版日期:2017-03-01
  • 通信作者: 丁红宇

Sonographic findings and pathological features of ductal carcinoma in situ without microcalcifications on mammography

Dequan Liu1, Hongyu Ding2,(), Jing Cui3, Hao Shi4, Kai Zhang5, Fengjing Fan5, Fei Li6   

  1. 1. Tai Shan Medical College, Taian 271000, China; Department of Ultrasound, People′s Hospital of Gaotang, Liaocheng 252800, China
    2. Department of Diagnostic Ultrasound, Shandong Provincial Qianfoshan Hospital, Jinan 250014, China
    3. Department of Pathology, Shandong Provincial Qianfoshan Hospital, Jinan 250014, China
    4. Department of Medical Imaging, Shandong Provincial Qianfoshan Hospital, Jinan 250014, China
    5. Tai Shan Medical College, Taian 271000, China
    6. School of Medicine, Shandong University, Jinan 250014, China
  • Received:2016-06-05 Published:2017-03-01
  • Corresponding author: Hongyu Ding
  • About author:
    Corresponding author: Ding Hongyu, Email:
引用本文:

刘德泉, 丁红宇, 崔晶, 史浩, 张凯, 范凤景, 李菲. 钼靶微钙化阴性乳腺单纯性导管内癌患者超声及病理表现[J/OL]. 中华医学超声杂志(电子版), 2017, 14(03): 226-231.

Dequan Liu, Hongyu Ding, Jing Cui, Hao Shi, Kai Zhang, Fengjing Fan, Fei Li. Sonographic findings and pathological features of ductal carcinoma in situ without microcalcifications on mammography[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2017, 14(03): 226-231.

目的

观察钼靶微钙化阴性乳腺单纯性导管内癌患者超声及病理表现。

方法

选取2010年1月至2016年2月在山东省千佛山医院就诊的40例乳腺单纯性导管内癌患者钼靶表现微钙化阴性病灶。分析钼靶微钙化阴性病灶超声表现,并根据声像图特征将其分为肿块型与非肿块型。同时,分析钼靶微钙化阴性病灶病理学亚型及核级。肿块型与非肿块型乳腺单纯性导管内癌患者超声诊断准确率、超声表现为微钙化比例及病理学核级与亚型情况比较采用Fisher确切概率法。

结果

40例钼靶微钙化阴性乳腺单纯性导管内癌患者病灶中,钼靶未发现异常者16例(40.0%),而超声未显示异常者仅1例(2.5%)。超声下,病灶更多表现为肿块型(75.0%,30/40),形状以圆形或卵圆形及不规则形为主,边缘呈细小分叶,内部呈不均质低回声与等回声,后方无回声特征,而非肿块型病灶(22.5%,9/40)则多表现为不均质中等回声合并导管扩张。40例钼靶微钙化阴性病灶5例(12.5%)超声下表现为微钙化。钼靶微钙化阴性病灶病理学上更多为中低核级(85.0%,34/40)与非粉刺亚型(87.5%,35/40)。肿块型病灶超声诊断准确率为73.3%(22/30),非肿块型病灶为33.3%(3/9),二者比较差异有统计学意义(P=0.047)。肿块型与非肿块型病灶在超声下表现为微钙化比例差异无统计学意义[10.0%(3/30)vs 22.2%(2/9),P=0.572]。肿块型与非肿块型病灶病理学核级及亚型差异均无统计学意义(P=1.000、0.070)。

结论

钼靶微钙化阴性乳腺单纯性导管内癌患者超声表现以肿块型为主,病理表现更多为中低核级与非粉刺亚型,超声更容易发现钼靶微钙化阴性病灶,应作为钼靶X线检查的补充,协助乳腺导管内癌的诊断,避免漏诊。

Objective

To investigate the characteristic sonographic and pathological features of breast ductal carcinoma in situ (DCIS) without microcalcifications on mammography (MG).

Methods

Forty cases of DCIS without microcalcifications on MG were retrospectively reviewed. The 40 lesions were classified into mass and non-mass groups according to their sonographic findings. The pathological subtypes and nuclear grades of these cases were also analyzed. Fisher exact test was used to compare the differences of the sonographic accuracy rate, sonographic microcalcification rate, pathological nuclear grade and subtype rate between mass and non-mass groups.

Results

No abnormal finding was found in sixteen cases (40.0%) on MG and only one case (2.5%) on ultrasonography (US), respectively. The most common sonographic feature of DCIS without microcalcifications on MG were masses (75.0%, 30/40), and other sonographic findings were round/oval and irregular shape, microlobulated margin, heterogeneous hypoechogenicity and isoechogenicity, and posterior acoustic feature. Ductal dilatations and heterogeneous isoechogenicity were present in most non-mass lesions of DCIS without microcalcifications on MG (22.5%, 9/40). The ultrasonographic microcalcifications were found in 5 cases of DCIS without microcalcifications on MG. The common pathological features of DCIS without microcalcifications on MG were medium-low nuclear grade (85.0%, 34/40) and noncomedo (87.5%, 35/40). The difference of US accuracy rate in mass and non-mass groups was statistically significant [73.3% (22/30) vs 33.3% (3/9), P=0.047]. The differences of US microcalcification rate, pathological subtype and nuclear grade were not significant (P=1.000, 0.070).

Conclusions

The mass appearance and medium-low nuclear grade were most common sonographic findings and pathological features of DCIS without microcalcifications on MG. Ultrasonography should be an helpful tool for improving the diagnostic sensitivity of mammography in breast DCIS.

图3,4 42岁钼靶微钙化阴性乳腺导管内癌患者非肿块型声像图合并微钙化。图3为右乳钼靶片,可见片状密度增高影,提示乳腺增生;图4为右乳声像图,显示内上象限腺体局限性结构紊乱,边缘模糊不清,内可见点状强回声并导管不规则扩张。术后病例证实为高核级非粉刺型乳腺导管内癌
表1 40例钼靶微钙化征阴性DCIS患者的病理亚型及核分级情况(例)
[1]
龙泉伊,李宏江. 乳腺导管内癌的诊断与治疗[J]. 华西医学, 2011, 26(7):1000-1002.
[2]
顾雅佳,王玖华,涂小予, 等. 乳腺导管原位癌的钼靶X线表现与病理对照研究[J]. 中华放射学杂志, 2002, 36(3):240-244.
[3]
朱庆莉,姜玉新,刘赫, 等. 常规超声结合超声弹性成像对乳腺导管内癌诊断的初步探讨[J]. 中国医学影像技术, 2008, 2(4):683-686.
[4]
Scoggins ME, Fox PS, Kuerer HM, et al. Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients [J]. AJR Am J Roentgenol, 2015, 204(4):878-888.
[5]
王建伟,林僖,赵静, 等. 超声与钼靶联合诊断乳腺导管内癌[J/CD]. 中华医学超声杂志(电子版), 2011, 8(6):45-48.
[6]
刘新杰,罗民,周冬仙, 等. 钙化与非钙化乳腺癌临床病理特征的比较[J]. 现代肿瘤医学, 2007, 15(11):1575-1577.
[7]
Berg WA, Campassi C, Langenberg P, et al. Breast imaging reporting and data system [M]// Encyclopedia of cancer. Berlin Heidelberg Springer, 2012: 1769-1777.
[8]
Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of tumours of the breast (IARC WHO Classification of Tumours) [M]. 4th ed. Lyon: IARC Press, 2012: 30-68.
[9]
Gradishar WJ, Anderson BO, Balassanian R, et al. Breast Cancer Version 2. 2015 [J]. J Natl Compr Canc Netw, 2015, 13(4):448-475.
[10]
杨光,张祥宏. 微钙化乳腺癌在钼靶片诊断中的价值及进展[J]. 国际医学放射学杂志, 2005, 28(6):410-412.
[11]
Neal CH, Coletti MC, Joe A, et al. Does digital mammography increase detection of high-risk breast lesions presenting as calcifications? [J]. AJR Am J Roentgenol, 2013, 201(5):1148-1154.
[12]
章瑜,梅海炳,王颖. 乳腺数字摄影中钙化灶对良恶性病变的诊断价值[J]. 中国医学影像技术, 2015, 32(4):567-570.
[13]
Newstead GM, et al. MR imaging of ductal carcinoma in situ [J]. Magn Reson Imaging Clin N Am, 2010, 18(2):225-240.
[14]
路红,付丽. 乳腺导管内癌的影像学与病理学对照研究进展[J/CD]. 中华乳腺病杂志(电子版), 2010, 4(6):5-8.
[15]
贺琰,王小燕,凌冰, 等. 乳腺导管内癌的超声图像及造影特征与病理对照分析[J]. 中国超声医学杂志, 2015, 31(6):494-497.
[16]
Moon WK, Im JG, Koh YH, et al. US of mammographically detected clustered microcalcifications [J]. Radiology, 2000, 217(3):849-854.
[17]
Yang WT, Tse GM. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ [J]. AJR Am J Roentgenol, 2004, 182(1):101-110.
[18]
Shin HJ, Kim HH, Kim SM, et al. Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features [J]. AJR Am J Roentgenol, 2008, 190(2):516-525.
[19]
Lee MH, Ko EY, Han BK, et al. Sonographic findings of pure ductal carcinoma in situ [J]. J Clin Ultrasound, 2013, 41(8):465-471.
[20]
蒋蓓琦,贺其志,章华, 等. 乳腺导管内癌超声声像图特征和临床病理的相关性研究[J]. 现代肿瘤医学, 2010, 18(2):287-290.
[21]
Hashimoto BE, Kramer DJ, Picozzi VJ. High detection rate of breast ductal carcinoma in situ calcifications on mammographically directed high-resolution sonography [J]. J Ultrasound Med, 2001, 20(5):501-508.
[22]
Huang CS, Wu CY, Chu JS, et al. Microcalcifications of non-palpable breast lesions detected by ultrasonography: correlation with mammography and histopathology [J]. Ultrasound Obstet Gynecol, 1999, 13(6):431-436.
[23]
Holland R. Ductal carcinoma in situ (DCIS) [J]. Breast Cancer Res, 2002, 4(1):1-1.
[24]
Rauch GM, Kuerer HM, Scoggins ME, et al. Clinicopathologic, mammographic, and sonographic features in 1187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status [J]. Breast Cancer Res Treat, 2013, 139(3):639-647.
[25]
Burstein HJ, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast [J]. N Engl J Med, 2004, 350(14):1430-1441.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[6] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[7] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[8] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[9] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[10] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[11] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[12] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[13] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[14] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?